Literature DB >> 2041103

Dispensable role of the human immunodeficiency virus type 2 Vpx protein in viral replication.

L Marcon1, F Michaels, N Hattori, K Fargnoli, R C Gallo, G Franchini.   

Abstract

Human immunodeficiency virus type 2 (HIV-2) is similar in genetic organization to HIV-1 but contains a unique gene (vpx) that encodes a 16-kDa protein. A replication-competent molecular clone of HIV-2 (HIV-2sbl/isy) that infects human primary cells in vitro and rhesus monkeys was used to generate three mutations in the vpx gene. In the first mutant, the vpx open reading frame was truncated at amino acid 20; the second mutant was tailored to eliminate the proline-rich carboxyl terminus of the protein; and the third mutant was obtained by addition of four amino acids (KDEL) to the carboxyl terminus of the protein to provide a retention signal in the endoplasmic reticulum. The viral infection kinetics of the three mutant viruses and isogeneic HIV-2sbl/isy in the SupT1 cell line were similar. Slight impairment in the early phases of viral replication was observed during infection of primary human peripheral blood mononuclear cells with the vpx mutant viruses. All of the vpx mutant viruses readily infected macrophages, indicating that vpx expression is dispensable for HIV-2 infection and replication in human macrophages.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2041103      PMCID: PMC241433     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

2.  Identification of a protein encoded by the vpu gene of HIV-1.

Authors:  E A Cohen; E F Terwilliger; J G Sodroski; W A Haseltine
Journal:  Nature       Date:  1988-08-11       Impact factor: 49.962

3.  New human T-lymphotropic retrovirus related to simian T-lymphotropic virus type III (STLV-IIIAGM).

Authors:  P J Kanki; F Barin; S M'Boup; J S Allan; J L Romet-Lemonne; R Marlink; M F McLane; T H Lee; B Arbeille; F Denis
Journal:  Science       Date:  1986-04-11       Impact factor: 47.728

4.  Isolation of an HTLV-III-related retrovirus from macaques with simian AIDS and its possible origin in asymptomatic mangabeys.

Authors:  M Murphey-Corb; L N Martin; S R Rangan; G B Baskin; B J Gormus; R H Wolf; W A Andes; M West; R C Montelaro
Journal:  Nature       Date:  1986 May 22-28       Impact factor: 49.962

5.  Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS.

Authors:  M G Sarngadharan; M Popovic; L Bruch; J Schüpbach; R C Gallo
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

6.  Seroepidemiological studies of human T-lymphotropic retrovirus type III in acquired immunodeficiency syndrome.

Authors:  B Safai; M G Sarngadharan; J E Groopman; K Arnett; M Popovic; A Sliski; J Schüpbach; R C Gallo
Journal:  Lancet       Date:  1984-06-30       Impact factor: 79.321

7.  Isolation of T-cell tropic HTLV-III-like retrovirus from macaques.

Authors:  M D Daniel; N L Letvin; N W King; M Kannagi; P K Sehgal; R D Hunt; P J Kanki; M Essex; R C Desrosiers
Journal:  Science       Date:  1985-06-07       Impact factor: 47.728

8.  Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

Authors:  F Barré-Sinoussi; J C Chermann; F Rey; M T Nugeyre; S Chamaret; J Gruest; C Dauguet; C Axler-Blin; F Vézinet-Brun; C Rouzioux; W Rozenbaum; L Montagnier
Journal:  Science       Date:  1983-05-20       Impact factor: 47.728

9.  Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS.

Authors:  R C Gallo; S Z Salahuddin; M Popovic; G M Shearer; M Kaplan; B F Haynes; T J Palker; R Redfield; J Oleske; B Safai
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

10.  Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS.

Authors:  M Popovic; M G Sarngadharan; E Read; R C Gallo
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

View more
  13 in total

1.  Variation of two primate lineage-specific residues in human SAMHD1 confers resistance to N terminus-targeted SIV Vpx proteins.

Authors:  Wei Wei; Haoran Guo; Qimeng Gao; Richard Markham; Xiao-Fang Yu
Journal:  J Virol       Date:  2013-10-30       Impact factor: 5.103

2.  Vpr of simian immunodeficiency virus of African green monkeys is required for replication in macaque macrophages and lymphocytes.

Authors:  B J Campbell; V M Hirsch
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

3.  Human immunodeficiency virus type 2 Vpx-Gag interaction.

Authors:  H A Pancio; L Ratner
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

4.  Role of the fusogenic peptide sequence in syncytium induction and infectivity of human immunodeficiency virus type 2.

Authors:  K R Steffy; G Kraus; D J Looney; F Wong-Staal
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

5.  A virion-specific inhibitory molecule with therapeutic potential for human immunodeficiency virus type 1.

Authors:  Z Matsuda; X Yu; Q C Yu; T H Lee; M Essex
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

6.  Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of gag and mutational analysis.

Authors:  W Paxton; R I Connor; N R Landau
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

7.  Localization of the Vpx packaging signal within the C terminus of the human immunodeficiency virus type 2 Gag precursor protein.

Authors:  X Wu; J A Conway; J Kim; J C Kappes
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

8.  Partial reverse transcripts in virions from human immunodeficiency and murine leukemia viruses.

Authors:  D Trono
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

9.  Vpx of simian immunodeficiency virus is localized primarily outside the virus core in mature virions.

Authors:  X Yu; Z Matsuda; Q C Yu; T H Lee; M Essex
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

10.  Antisense phosphorothioate oligodeoxynucleotides targeted to the vpr gene inhibit human immunodeficiency virus type 1 replication in primary human macrophages.

Authors:  C Balotta; P Lusso; R Crowley; R C Gallo; G Franchini
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.